Type 2 Inflammation News

News

Utilization Increases and Spending Decreases With Preventive Drug Lists for Asthma Medications

11/29/2023

Reducing cost-sharing for asthma medications through a preventive drug list (PDL) increases adherence to controller medications, according to a study published in JAMA Network Open.

Reducing cost-sharing for asthma...

11/29/2023

First Report Managed Care

News

Asthma Management Critical During Pregnancy

11/21/2023

Jolynn Tumolo ;

Potential roadblocks to adequate management of asthma in pregnant women include nonadherence to medication, lack of education, and smoking habits. The review mentions a retrospective study that found pregnant women with asthma tended to...

Potential roadblocks to adequate...

11/21/2023

First Report Managed Care

News

The Role of Fungi in Allergic Disease and the Evolutionary Advantage of Type 2 Immune Response

11/07/2023

Hannah Musick ;

This article highlights the global rise in allergic diseases and the significant economic burden they pose, focusing on the role of fungi in triggering allergic reactions and the need for further research to understand why type 2 immune...

This article highlights the...

11/07/2023

First Report Managed Care

News

Biologics for Asthma: Targeting Type 2 Inflammation in Severe Cases

10/13/2023

Danielle Sposato ;

Currently, most biologics used to treat asthma are approved for individuals with uncontrolled moderate-to-severe asthma and elevated biomarkers of type 2 (T2) inflammation, driven by T2 cytokines like IL-4, IL-13, and IL-5, according to a...

Currently, most biologics used...

10/13/2023

First Report Managed Care

News

Satellite Data Reveals a Link Between NO2 Exposure and Asthma Exacerbations

10/02/2023

Lisa Kuhns , PhD, MD;

Incorporating ground-level satellite-derived estimates of NO2 into multivariable models reveals a relationship between NO2 exposure and asthma exacerbations, according to a study published in AMIA Joint Summits on Translational Science.

Incorporating ground-level...

10/02/2023

First Report Managed Care

News

Using Socioeconomic, Insurance Status to Help Identify Risk Factors for Uncontrolled Asthma in a US Cohort

09/20/2023

Julie Gould ;

"Socioeconomic and insurance status, asthma severity, and prior health care utilization have been shown to predict the risk of hospitalization, in the US," explained authors. "Thus, identifying patients who are at the higher risk for...

"Socioeconomic and insurance...

09/20/2023

First Report Managed Care

News

Modulating ILC2s in Allergic Airway Inflammation for Therapeutic Intervention

09/18/2023

Danielle Sposato ;

In a study addressing limitations in previous research, scientists investigate the role of acetylcholine (ACh) in allergic airway inflammation, emphasizing the challenges in distinguishing direct effects on group 2 innate lymphoid cells...

In a study addressing...

09/18/2023

First Report Managed Care

News

Ongoing Study of IL-23 in Asthma May Yield More Treatment Options

09/11/2023

Jolynn Tumolo ;

A new study suggests that gaining a better understanding of the relationship between interleukin (IL)-23 and airway inflammation in asthma patients could lead to alternative treatment options beyond traditional anti-type 2 inflammatory...

A new study suggests that...

09/11/2023

First Report Managed Care

News

New Platform Leverages Real-World Evidence for Type 2 Inflammation Immunological Disease Research

08/07/2023

Hannah Musick ;

Researchers introduce Immunolab, a platform that generates real-world evidence to provide insights and conduct research on immunological diseases related to type 2 inflammation.

Researchers introduce Immunolab,...

08/07/2023

First Report Managed Care

News

Therapy Benefits People With Type 2 Asthma Regardless of Inhaled Corticosteroid Dose

08/01/2023

Jolynn Tumolo ;

New findings indicate a biologic therapy was efficacious for up to 3 years in patients with uncontrolled, moderate-to-severe asthma.

New findings indicate a biologic...

08/01/2023

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

In Reversal, Florida to Take Health Law’s Medicaid Expansion

02/21/2013

First Report Managed Care

News

Alemtuzumab Reduces Disability From Relapsing-Remitting Multiple Sclerosis

10/21/2016

Alemtuzumab reduces preexisting disability in patients with active relapsing-remitting multiple sclerosis (RRMS), compared with subcutaneous interferon, according to results from the CARE-MS II study.

Alemtuzumab reduces preexisting...

10/21/2016

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Type 2 Inflammation News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products